The HDL Handbook

The HDL Handbook

Biological Functions and Clinical Implications

2nd Edition - October 16, 2013

Write a review

  • Editor: Tsugikazu Komoda
  • eBook ISBN: 9780124079243
  • Hardcover ISBN: 9780124078673

Purchase options

Purchase options
DRM-free (Mobi, PDF, EPub)
Available
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

The HDL Handbook: Biological Functions to Clinical Implications brings laboratory research in HDL from bench to bedside in this needed resource for researchers and clinicians studying cholesterol, lipids, epidemiology, biochemistry, molecular medicine, and pathophysiology of cardiovascular diseases. In addition, researchers and clinicians working with an aging population, corporate researchers, post-doctorates; medical students and graduate students will find this publication useful because the scope of coverage includes basic science, genetics, epidemiology, and treatment of HDL cholesterol as well as potential targets to modify HDL cholesterol.

Key Features

  • Provides bench-to-bedside coverage of HDL with thorough coverage of basic science, genetics, epidemiology, and treatment
  • Presents a complete update with six new chapters on the latest advances in HDL cholesterol research with international perspective
  • New chapters on proteomics, clinical impact of LCAT in HDL metabolism, and an in-depth discussion of potential targets to modify HDL provide a translational reference for clinicians

Readership

Researchers and clinicians studying cholesterol, lipids, epidemiology, biochemistry, molecular biology, molecular medicine, and pathophysiology of cardiovascular diseases; researchers and clinicians working with an aging population; corporate researchers; postdocs; medical students and graduate students. Allied health professionals, nurses, and researchers and clinicians studying nutrition

Table of Contents

  • Chapter 1. Introduction of HDL Molecules, Past and Brief Future

    Abstract

    1 Introduction

    2 HDL May be an Independent Predictor of CHD

    3 High Levels of HDL Sometimes Cause Atherosclerosis: the Example of CETP Deficiency

    4 Is HDL-C Really “Good Cholesterol”?

    5 Quantitative and Qualitative Measurement of HDL-C Molecules

    6 Conclusion

    References

    Chapter 2. Apolipoprotein A-I Mutations and Clinical Evaluation

    Abstract

    1 Introduction

    2 Physiological Functions of apoA-I

    3 Genomic and Protein Structure of apoA-I

    4 ApoA-I Deficiencies with Large Deficiency, Inversion, Nonsense, or Frameshift Mutations

    5 ApoA-I Missense Mutations with Low HDL-C

    6 ApoA-I Mutations Related to Amyloidosis

    7 Cysteine Mutants of apoA-I

    8 Anti-Atherogenic apoA-I and apoA-IMilano

    9 Conclusion

    References

    Chapter 3. The Complexity of High-Density Lipoproteins

    Abstract

    1 HDL and Cardiovascular Disease

    2 What is HDL?

    3 HDL Metabolism

    4 Moderators of HDL Particle Distribution and Composition

    5 HDL Structure

    6 HDL Proteomics

    7 HDL Functions

    8 The Future of HDL Research

    References

    Chapter 4. Reverse Cholesterol Transport in HDL Metabolism: Modulation of Structural and Functional Features of HDL Particles

    Abstract

    1 Overall Mechanism of the Reverse Cholesterol Transport

    2 Relationship Between HDL Structure and Function in Reverse Cholesterol Transport

    3 Metabolic Disorders Associated with a Low HDL-C Phenotype and Dysfunctional HDL Particles

    4 Inflammatory States Associated with Altered HDL Function in Reverse Cholesterol Transport

    5 Genetic Variants Associated with Altered HDL Function in Reverse Cholesterol Transport

    6 Conclusion

    References

    Chapter 5. Role of ATP-Binding Cassette Transporters A1 and G1 in Reverse Cholesterol Transport and Atherosclerosis

    Abstract

    1 Introduction

    2 The Role of Reverse Cholesterol Transport in Lipid Metabolism

    3 Major Pathways for Cellular Cholesterol Efflux

    4 Mechanisms for Cholesterol Efflux and Generation of Nascent HDL: Role of ABCA1

    5 Mechanisms for Maturation of HDL Particles and Maintenance of Circulating HDL Levels: Role of ABCA1

    6 The Role of ABCG1 in Cholesterol Efflux and HDL Metabolism

    7 Transcriptional Regulation of ABCA1/G1

    8 Posttranscriptional/Posttranslational Regulation of ABCA1/G1

    9 The Role of ABCA1/G1 in Reverse Cholesterol Transport and Atherosclerosis in Animal Models

    10 The Role of ABCA1/G1 in Atherosclerosis in Humans

    11 Therapeutic Strategies Against Atherosclerosis Involving RCT Modification

    12 Conclusion

    References

    Chapter 6. Sphingolipids and HDL Metabolism

    Abstract

    1 Introduction

    2 Plasma HDL-SM Origination

    3 Sphingolipid De Novo Synthesis and HDL Metabolism

    4 Plasma SM and HDL Metabolism

    5 Plasma S1P and HDL Metabolism

    6 Plasma Membrane Sphingolipid Levels and Cholesterol Efflux

    7 Sphingolipids and Atherosclerosis

    8 Conclusion

    References

    Chapter 7. Role of Lecithin: Cholesterol Acyltransferase in HDL Metabolism and Atherosclerosis

    Abstract

    1 Introduction

    2 LCAT Biochemistry

    3 The Role of LCAT on Reverse Cholesterol Transport

    4 Familial LCAT Deficiency and Fish-Eye Disease: Clinical Signs and Symptoms

    5 Animal Models Exploring the Functional Role of LCAT

    6 LCAT and its Role in Atherosclerosis in Human Studies

    7 LCAT-Based Therapies

    8 Conclusion

    References

    Chapter 8. Cholesteryl Ester Transfer Protein Inhibitors: A Hope Remains

    Abstract

    1 Introduction

    2 HDL-TG as a Key Component Determining Neutral Lipid Transfer

    3 HDL Metabolism in CETP Deficiency

    4 LDL Metabolism in CETP Deficiency

    5 VLDL Metabolism in CETP Deficiency

    6 Antioxidant Activity in CETP Deficiency

    7 Difference of Lipoprotein Phenotype Between Homozygotes and Heterozygotes with CETP Deficiency

    8 Source of CETP and Cholesteryl Ester Transfer (CET) Determinant

    9 Drug Designs in Clinical Trials

    10 Structural Difference of CETP Inhibitors in the Cavity of CETP

    11 Differential Effects Among CETP Inhibitors

    12 Perspective of CETP Inhibitor

    13 Conclusion

    References

    Chapter 9. HDL Apoprotein Mimetic Peptides as Anti-Inflammatory Molecules

    Abstract

    Key Concepts

    1 Introduction

    2 apoA-I and the History of its Derived Mimetic Peptides

    3 Anti-Atherogenic Effects of apoA-I Mimetic Peptides

    4 Anti-Inflammatory Properties of apoA-I Mimetic Peptides With Cells in Culture

    5 In Vivo Anti-Inflammatory Properties of apoA-I-Derived Mimetic Peptides

    6 Hybrid and apoE Mimetics

    7 Conclusion

    References

    Chapter 10. Oxidized High-Density Lipoprotein: Friend or Foe

    Abstract

    1 Introduction

    2 Clinical Relevance of oxHDL to Vascular-Related Diseases

    3 Structural Alterations in HDL Components by Oxidation

    4 Functional Alterations in HDL by Oxidation

    5 Is oxHDL Friend or Foe?

    6 Conclusion

    References

    Chapter 11. Current Aspects of Paraoxonase-1 Research

    Abstract

    Key Concepts

    1 Introduction

    2 PON1 and Atherosclerosis

    3 Dysfunctional HDL

    4 PON1 and Other Inflammatory Diseases

    5 PON1 and Organophosphate Toxicity

    6 PON1 and Cancer

    7 PON1 and Quorum Quenching

    8 PON1 and Aging

    9 Conclusion

    References

    Chapter 12. Proteomic Diversity in HDL: A Driving Force for Particle Function and Target for Therapeutic Intervention

    Abstract

    Key concepts

    1 Introduction to HDL-Associated Proteins

    2 The Proteomic Diversity of HDL

    3 Proteomic Subspeciation of HDL

    4 Influence of Disease on the HDL Proteome

    5 HDL Proteins as Therapeutic Targets

    6 Challenges of MS-Based Analyses of the HDL Proteome

    7 Conclusion

Product details

  • No. of pages: 354
  • Language: English
  • Copyright: © Academic Press 2013
  • Published: October 16, 2013
  • Imprint: Academic Press
  • eBook ISBN: 9780124079243
  • Hardcover ISBN: 9780124078673

About the Editor

Tsugikazu Komoda

Tsugikazu Komoda
Dr. Komoda is a visiting professor at Toho University School of Medicine in Japan. He has extensive expertise with research in alkaline phosphatase, amylase, and oxidized HDL. He co-operated the intestinal alkaline phosphatase at Washington University School of Medicine in St. Louis, Missouri. He is the recipient of the Kodama Memorial Award from Japanese Society of Electrophoresis.

Affiliations and Expertise

Visiting Professor, Toho University School of Medicine, Japan

Ratings and Reviews

Write a review

There are currently no reviews for "The HDL Handbook"